A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis (MS) report lower levels of depression and higher quality of life than their younger counterparts. These findings are consistent with the trend toward improvement in well-being with age in the general population. The article, “Subjective well-being differs with age […]Continue Reading ...
Source: Getty Images In a phase 2 clinical trial, an investigational anti-inflammatory drug called ibudilast was found to be superior to placebo in slowing the progression of brain atrophy in patients with progressive multiple sclerosis. The study, conducted at 28 sites around the country, including Columbia University Irving Medical Center, was published last month in […]Continue Reading ...
LA JOLLA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the New England Journal of Medicine has published results of the SPRINT-MS Phase 2b trial of MN-166 (ibudilast) in […]Continue Reading ...
A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These cells activate T cells in the blood. This […]Continue Reading ...
August 22, 2018 Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the individualized nature of the disease. MS has long been characterized as a disease of the brain’s white matter, where immune cells destroy myelin – the fatty protective covering on nerve cells. The destruction of […]Continue Reading ...
July 20, 2018 Glenn Wylie, DPhil, associate director of the Rocco Ortenzio Neuroimaging Center (RONIC) at Kessler Foundation, has received a $300,000 sub-award from the National Institutes of Health (NIH) for a collaborative study with the University of Alabama at Birmingham (UAB). Cognitive impairment is prevalent in persons with multiple sclerosis (MS), yet often poorly […]Continue Reading ...
July 16, 2018 During the five years before people develop the first clinically recognized signs of multiple sclerosis (MS), they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research […]Continue Reading ...
TUESDAY, July 3, 2018 — A triple whammy of genetics, smoking, and exposure to paints and solvents at work puts a person at extremely high risk of developing multiple sclerosis, Swedish researchers report. On its own, any one factor elevates the risk for the central nervous system disease substantially, the investigators said. But when all […]Continue Reading ...
Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis (MS) Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS. This four-year award funds a collaborative study with 11 centers across six countries, […]Continue Reading ...
In multiple sclerosis (MS), not only the T cells of the immune system, but also its B cells, play an important role. This is shown by researchers at Karolinska Institutet and the University of Zurich in a study published in the journal Cell. The findings explain how a new class of MS drugs works, and […]Continue Reading ...
A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease. The definitive results of the phase 2 trial – published in the New England Journal of Medicine – showed that […]Continue Reading ...
By Sally Robertson, BScJuly 17, 2018 A study led by researchers at the University of Buffalo has shown that an advanced MRI technique can help to identify patients with multiple sclerosis (MS) who are at an increased risk of developing a physical disability. Image Credit: sfam_photo / Shutterstock Lead author Robert Zivadinov hopes the technique, […]Continue Reading ...
July 10, 2018 People with multiple sclerosis (MS) can find an abundance of conflicting advice suggesting that special diets – everything from avoiding processed foods to going low-carb – will ease their symptoms. But the evidence is scanty that dietary changes can improve fatigue or other MS symptoms. “People hear these miraculous stories about patients […]Continue Reading ...
July 4, 2018 People who have been exposed to paint, varnish and other solvents and who also carry genes that make them more susceptible to developing multiple sclerosis (MS) may be at much greater risk of developing the disease than people who have only the exposure to solvents or the MS genes, according to a […]Continue Reading ...
- CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
- Study offers solid link between visceral organs and brain’s reward, motivation system
- First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute
- Choroidal Detachment – The American Society of Retina Specialists
- Discovery of a key protein involved in the development of autism
- Henry Ford Health System receives $600k grant to study genetic makeup of gliomas
- Arthritis common in individuals with varying degrees of depression, finds study
- New research suggests link between PFAS chemicals and hyperthyroidism in pet cats
- Multi-year study data shows impact of new soft contact lens to slow myopia progression in children
- Neuroscientists identify circuit for brain’s statistical inference about motion
- MILabs’ VECTor6 system wins Commercial Innovation Award at WMIC 2018
- Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans
- 2006 to 2015 Saw Increase in Severe Maternal Morbidity
- Similar changes in the brains of patients with ADHD and emotional instability
- Cobalt mining in DR Congo takes a high toll on both creuseurs and environment
- Eating fatty fish during pregnancy may boost unborn child’s brain development
- Study reveals promising new drug candidate to treat acute renal failure
- Neural signal that urges to eat overpowers the one that says to stop
- Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens
- Researchers simulate how different breast tissues respond to heat from MRIs